Search by Drug Name or NDC
NDC 25021-0193-02 Lincomycin 300 mg/mL Details
Lincomycin 300 mg/mL
Lincomycin is a INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is LINCOMYCIN HYDROCHLORIDE.
Product Information
| NDC | 25021-0193 |
|---|---|
| Product ID | 25021-193_36277638-639e-4141-9ad0-a5afaa12043b |
| Associated GPIs | |
| GCN Sequence Number | 009338 |
| GCN Sequence Number Description | lincomycin HCl VIAL 300 MG/ML INJECTION |
| HIC3 | W1K |
| HIC3 Description | LINCOSAMIDE ANTIBIOTICS |
| GCN | 40810 |
| HICL Sequence Number | 004043 |
| HICL Sequence Number Description | LINCOMYCIN HCL |
| Brand/Generic | Generic |
| Proprietary Name | Lincomycin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lincomycin Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/mL |
| Substance Name | LINCOMYCIN HYDROCHLORIDE |
| Labeler Name | Sagent Pharmaceuticals |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215657 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 25021-0193-02 (25021019302)
| NDC Package Code | 25021-193-02 |
|---|---|
| Billing NDC | 25021019302 |
| Package | 10 VIAL in 1 CARTON (25021-193-02) / 2 mL in 1 VIAL |
| Marketing Start Date | 2023-04-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |